ctrl K

Price Alert

POINT Biopharma Global In... (PNT)

NASDAQ: PNT · Real-Time Price · USD

12.50

0.02 (0.16%)

At close: Dec 26, 2023, 10:00 PM

POINT Biopharma Global Revenue Breakdown

Period Ending	Dec 31, 2022
License Revenue	225.16M
License Revenue Growth	n/a
Product and Service, Other Revenue	1.41M
Product and Service, Other Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Selling, General, and Administrative Revenue	5.51M	5.09M	5.01M	7.28M	3.84M	4.08M	3.81M	4.57M	4.03M	1.95M	1.46M	1.29M	596.16K	1.07M
Selling, General, and Administrative Revenue Growth	+8.20%	+1.56%	-31.17%	+89.57%	-5.90%	+7.16%	-16.59%	+13.38%	+106.54%	+33.10%	+13.94%	+115.63%	-44.14%	n/a
Research and Development Revenue	26.91M	31.28M	26.91M	27.94M	20.8M	20.81M	12.5M	9.53M	13M	6.7M	4.27M	4.12M	2.48M	2.16M
Research and Development Revenue Growth	-13.96%	+16.22%	-3.68%	+34.34%	-0.08%	+66.50%	+31.17%	-26.71%	+94.07%	+56.95%	+3.69%	+66.01%	+14.85%	n/a